Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000757162 | SCV000885292 | uncertain significance | not provided | 2017-05-14 | criteria provided, single submitter | clinical testing | The p.Gln1836Glu variant (rs770845480) has not been reported in the medical literature, gene specific variation databases, nor has it been previously identified by our laboratory. This variant is listed in the Exome Aggregation Consortium Browser with an overall population frequency of 0.001 percent (identified on 1 out of 85,550 chromosomes). The glutamine at position 1836 is moderately conserved (considering 7 species, Alamut v.2.9.0) and computational analyses of the effects of the p.Gln1836Glu variant on protein structure and function provide conflicting results (SIFT: tolerated, PolyPhen-2: benign). Altogether, there is not enough evidence to classify the p.Gln1836Glu variant with certainty. |
Fulgent Genetics, |
RCV002507329 | SCV002816905 | uncertain significance | Becker muscular dystrophy; Duchenne muscular dystrophy; Dilated cardiomyopathy 3B | 2021-07-26 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001825497 | SCV002093495 | uncertain significance | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2018-08-21 | no assertion criteria provided | clinical testing |